Sort
48,018 grants matching “immunotherapy”
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,365Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,364Nupam P Mahajan · Washington University · R01 · FY2023 · CA
Regulation of ER-beta Signaling in Carcinogenesis
$484,266Rong Li · George Washington University · R01 · FY2021 · CA
Quantitative modeling of the phenotypic variability of individual T cells and the
$484,215Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI
Administrative Core
$484,203Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$484,169Antoni Ribas · California Institute Of Technology · P01 · FY2014 · CA
Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy
$484,138Heiko Enderling · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2022 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$484,099Wafik S El-Deiry · Brown University · R01 · FY2021 · CA
Understanding CDK1 Function and Cancer Vulnerabilities
$484,012Andrei Goga · University Of California, San Francisco · R01 · FY2025 · CA
Preclinical development and clinical monitoring of adoptive immune therapy
$483,898Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Regulation of Lymphocyte Development by HLH Proteins
$483,878Barbara Lynne Kee · University Of Chicago · R01 · FY2015 · AI
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$483,859Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Understanding CDK1 Function and Cancer Vulnerabilities
$483,857Andrei Goga · University Of California, San Francisco · R01 · FY2023 · CA
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approach
$483,799Laura K Fonken · University Of Texas At Austin · R01 · FY2021 · AG
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approach
$483,799Laura K Fonken · University Of Texas At Austin · R01 · FY2024 · AG
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approach
$483,799Laura K Fonken · University Of Texas At Austin · R01 · FY2023 · AG
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approach
$483,799Laura K Fonken · University Of Texas At Austin · R01 · FY2022 · AG
Metabolomics Technologies to Advance Biomedical Research
$483,750Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2022 · GM
Metabolomics Technologies to Advance Biomedical Research
$483,750Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2021 · GM
Metabolomics Technologies to Advance Biomedical Research
$483,750Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2019 · GM
Metabolomics Technologies to Advance Biomedical Research
$483,750Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2023 · GM
Metabolomics Technologies to Advance Biomedical Research
$483,750Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2020 · GM